Vera Therapeutics, Inc. (VERA) Earnings

Vera Therapeutics, Inc. is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-1.60. VERA has beaten EPS estimates in 4 of its last 12 reported quarters (average surprise -10.5% over the last four).

Next earnings
Aug 4, 2026in NaN days
EPS est $-1.60 · Revenue est $1M
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -10.5% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-1.33$-1.69-27.2%
Nov 5, 2025$-1.20$-1.26-5.0%
Feb 26, 2025$-0.83$-0.72+13.3%
Nov 7, 2024$-0.69$-0.85-23.2%
Aug 8, 2024$-0.58$-0.62-6.9%
May 9, 2024$-0.53$-0.56-5.7%
Mar 20, 2024$-0.53$-0.58-9.4%
Nov 9, 2023$-0.50$-0.45+10.0%
Aug 10, 2023$-0.69$-0.46+33.3%
May 11, 2023$-0.60$-0.80-33.3%
Nov 9, 2022$-0.72$-0.91-26.4%
Aug 10, 2022$-0.72$-0.55+23.6%

Source: company filings + earnings calendar. For informational purposes only — not investment advice.